Jenoptik (JEN) Given a €30.00 Price Target by HSBC Analysts

Jenoptik (ETR:JEN) received a €30.00 ($34.88) target price from investment analysts at HSBC in a research note issued to investors on Thursday. The brokerage currently has a “neutral” rating on the stock. HSBC’s target price indicates a potential downside of 3.60% from the stock’s previous close.

A number of other equities research analysts have also issued reports on the company. Kepler Capital Markets set a €34.50 ($40.12) target price on Jenoptik and gave the company a “neutral” rating in a research report on Wednesday. DZ Bank reissued a “neutral” rating on shares of Jenoptik in a research report on Wednesday. Baader Bank set a €30.00 ($34.88) target price on Jenoptik and gave the company a “neutral” rating in a research report on Wednesday. Hauck & Aufhaeuser set a €32.50 ($37.79) target price on Jenoptik and gave the company a “buy” rating in a research report on Wednesday. Finally, Warburg Research set a €33.00 ($38.37) target price on Jenoptik and gave the company a “buy” rating in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of €31.29 ($36.38).

ETR:JEN opened at €31.12 ($36.19) on Thursday. Jenoptik has a fifty-two week low of €20.68 ($24.05) and a fifty-two week high of €34.82 ($40.49).

Jenoptik Company Profile

Jenoptik AG operates as an integrated photonics company in Germany and internationally. The company's Opticals & Life Science division develops and manufactures micro-optics for beam shaping for use in the semiconductor industry, as well as for laser material processing; and optical systems and components for information and communication, security, and defense technologies.

Read More: Lock-Up Period Expiration

Analyst Recommendations for Jenoptik (ETR:JEN)

Receive News & Ratings for Jenoptik Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jenoptik and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit